EPI-743 phase 2b

Edison Pharmaceuticals has launched a phase 2b trial to test its small-molecule drug EPI-743 in adults with Friedreich's ataxia

posted on January 16, 2013 - 5:00am
Update (Dec.

New content is being added every day. Please check back again.